Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/28/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Alfredo F. Galvez

Wrong Dr. Alfredo F. Galvez?

Leading Researcher

Soy Labs LLC
651 Commerce Road
Mexico , Missouri 65265
United States

Company Description: Soy Labs, LLC is a research-driven nutraceutical company dedicated to improving the quality of life for consumers through next-generation, soy-based nutritional...   more

Employment History

  • Director of Research
    Missouri Plant Science Center
  • Center Scientist (Collaborator)
    UC Davis
  • Research Scientist At the Center of Excellence In Nutritional Genomics
    UC Davis
  • Molecular Biologist At the NCMHD Center for Excellence In Nutritional Genomics
    UC Davis
  • Adjunct Assistant Professor
    University of Missouri
  • Center Scientist
    Center of Excellence for Nutritional Genomics
  • Research Scientist
    Center of Excellence for Nutritional Genomics
  • Lead Scientist
    Center of Excellence for Nutritional Genomics
  • Research Scientist
    USDA and UC Berkeley
  • Research Geneticist
    USDA and UC Berkeley

Board Memberships and Affiliations

  • Scientific Advisor
    Soy Labs LLC
  • Lead Scientific Advisor
    Missouri Plant Science Center
  • Chief Scientific Advisor
  • Lead Scientific Advisor
    The MPSC


  • University of the Philippines
  • Masters
  • PhD , Genetics and Molecular Biology
    UC Davis
40 Total References
Web References
SoyLabs Research & Projects, 28 Dec 2014 [cached]
Lunasin was first discovered in 1996 by Dr. Alfredo Galvez, Soy Labs' leading researcher, as a result of his research to improve the nutritional profile of soy protein at the University of California, Berkeley.
Dr. Galvez realized that this impressive soy peptide, which is found in small quantities in soybean seeds and soy-based foods, blocks cell division by binding to specific chromosomal proteins called "hypoacetylated histones. Because there is consistent epidemiological data regarding soy and cancer prevention, Lunasin was first investigated as a factor that might prevent cancer cells from dividing and multiplying. The mechanism of action for Lunasin and cancer prevention was included in prestigious journals, such as Nature Biotechnology and the Journal of Cancer Research. As Dr. Galvez continued to study Lunasin, it became evident that the soy peptide had another powerful mechanism of action- lowering cholesterol.
According to Dr. Alfredo ... [cached]
According to Dr. Alfredo Galvez, lead scientific advisor with Missouri-based Soy Labs, LLC, some of the "megatrends" that are driving the nutrition market in general are directly impacting this category."An aging population, lack of confidence in traditional health care systems and globalization/consumer access to information are compelling shoppers to be proactive and seek alternative solutions to their health concerns," he said.
"Most cholesterol is produced in the liver by the HMG-CoA reductase gene.Statin drugs work by blocking HMGCoA, but they can often block too much," Galvez explained. "This leads to serious side effects because our body needs a minimum level of cholesterol for proper cellular functions such as maintaining cell membrane integrity and hormone production. According to Galvez, lunasin works differently: it targets cholesterol at an earlier stage than statins, reducing the HMG-CoA without blocking it entirely. "Lunasin demonstrates superior support for cardiovascular health and exhibits significant anti-inflammatory properties," he added.
Compared to statins, lunasin works at an earlier stage in the process than prescription statins by reducing the expression of the HMG-CoA Reductase gene, according to Galvez.
"While cholesterol is an accepted biomarker for identifying the risk factors associated with cardiovascular disease, other potential biomarkers (e.g. inflammation markers, circulating free fatty acids, etc.) are being identified that may play and equally important role in heart health," Galvez agreed. "The key to future innovations in this segment will be finding bioactive compounds that work synergistically to support heart health by addressing the many inter-related health indicators."
Further, a new take on statins may be forthcoming. "Recently research is considering the use of low-dose statin treatment for primary prevention of cardiovascular disease," Galvez added.
Presenters will include Dr. Carl ..., 28 June 2013 [cached]
Presenters will include Dr. Carl Hastings, Reliv chief scientific officer, and Dr. Alfredo Galvez, research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at the Missouri Plant Science Center (MPSC).
Galvez will present the latest lunasin research, describe the emergence of epigenetics as a new frontier in our understanding of human health and discuss the potential applications for nutritional epigenetics in the future of health care.
"No other company is advancing the field of nutritional epigenetics like Reliv," said Galvez.
"Most of the changes affecting your ..., 30 Sept 2013 [cached]
"Most of the changes affecting your health don't occur in the genes themselves; they happen in the epigenetic switches," said Dr. Alfredo Galvez, Chief Scientific Advisor at SL Technology, Inc., a Reliv subsidiary. - Archive for January, 2012, 1 Jan 2012 [cached]
"A growing body of research shows that the lunasin peptide is one of the most important bioactive components of soy," said Dr. Alfredo Galvez, the MPSC's lead scientific advisor. "In creating LunaRich for Reliv, we have maximized lunasin levels in a soy powder."
Dr. Galvez first discovered lunasin in 1996 during research at UC Berkley to improve the nutritional profile of soy protein. More than 40 peer-reviewed and published studies have documented lunasin's health benefits. Research by 21 institutions supported by 27 public and private funding sources has resulted in nine patents.
Other People with the name "Galvez":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.